PSMA & Lutetium-177 in 2022 | Eugene Kwon, MD | DIY Combat Manual for Beating Prostate Cancer Part 4

Advanced #ProstateCancer Treatments | Eugene Kwon, MD | DIY Combat Manual | Part 5 #PCRIПодробнее

Advanced #ProstateCancer Treatments | Eugene Kwon, MD | DIY Combat Manual | Part 5 #PCRI

PSMA Scans & Pluvicto (lutetium-177) in 2022 | Geoffrey Johnson, MD, PhD | PCRI Conference 2022Подробнее

PSMA Scans & Pluvicto (lutetium-177) in 2022 | Geoffrey Johnson, MD, PhD | PCRI Conference 2022

Prostate Cancer Recurrence | Eugene Kwon, MD | DIY Combat Manual for Beating Prostate Cancer: Part 2Подробнее

Prostate Cancer Recurrence | Eugene Kwon, MD | DIY Combat Manual for Beating Prostate Cancer: Part 2

Prostate Cancer Treatments | Eugene Kwon, MD | DIY Combat Manual for Beating Prostate Cancer: Part 3Подробнее

Prostate Cancer Treatments | Eugene Kwon, MD | DIY Combat Manual for Beating Prostate Cancer: Part 3

PET Imaging | Eugene Kwon, MD | DIY Combat Manual for Beating Prostate Cancer: Part 1 | PCRI 2021Подробнее

PET Imaging | Eugene Kwon, MD | DIY Combat Manual for Beating Prostate Cancer: Part 1 | PCRI 2021

PSMA & Lutetium-177 in 2022 | Eugene Kwon, MD | DIY Combat Manual for Beating Prostate Cancer Part 4Подробнее

PSMA & Lutetium-177 in 2022 | Eugene Kwon, MD | DIY Combat Manual for Beating Prostate Cancer Part 4

Treatment, Imaging, & More | Q+A with Eugene Kwon, MD & Mark Moyad, MD | 2021 PCRI ConferenceПодробнее

Treatment, Imaging, & More | Q+A with Eugene Kwon, MD & Mark Moyad, MD | 2021 PCRI Conference

Day 2 | Advanced Treatments, LU-177, Extended Q+A | 2022 Prostate Cancer Patient ConferenceПодробнее

Day 2 | Advanced Treatments, LU-177, Extended Q+A | 2022 Prostate Cancer Patient Conference

Lutetium-177 and Bipolar Androgen Therapy: Future Game Changers In Prostate Cancer | PCRIПодробнее

Lutetium-177 and Bipolar Androgen Therapy: Future Game Changers In Prostate Cancer | PCRI

177 Lu PSMA Treatment for Prostate Cancer (Update: FDA approved on 3/23/22)Подробнее

177 Lu PSMA Treatment for Prostate Cancer (Update: FDA approved on 3/23/22)

New FDA Approved: Pluvicto (Lutetium-177) for Advanced Prostate Cancer | Mark Scholz, MD | PCRIПодробнее

New FDA Approved: Pluvicto (Lutetium-177) for Advanced Prostate Cancer | Mark Scholz, MD | PCRI

Does Sugar Feed Prostate Cancer? Does Fatty/Adipose Tissue Attract Cancer? | Mark Moyad, MD, MPHПодробнее

Does Sugar Feed Prostate Cancer? Does Fatty/Adipose Tissue Attract Cancer? | Mark Moyad, MD, MPH